Meet the Resident:Eila Arich-Landkof Ph.D. Founder & CEO, Oriel Research Therapeutics

Eila Arich-Landkof-family

As a CEO, what’s your advice for a researcher who wants to launch a startup?

My main advice would be to get hands on experience in the industry. In my view, the combination of industry experience with academic skills is a good recipe for success. As a researcher, you have a broad academic background, so completing it with the insight of how a company operates is very helpful.

How has being a resident of JPOD @ Boston helped you advance your company?

I work closely with the JPOD oncology leadership team, who are very professional and are good colleagues. The team from JPOD was instrumental in helping me develop a good strategy to validate ORT’s early detection for Acute Myeloid Leukemia (AML). Early detection is considered to be an uncharted territory that requires a lot of validation creativity, but thanks to the help from the JPOD team, ORT’s blood test for AML is being validated by Pharma approved methods.

What are you reading, listening, or watching that you would recommend?

I am listening to YouTube talks on the topics of precision medicine, biology, and cloud software development. I also recommend listening to realy_cool_kid on Spotify, which has an amazing playlist of 70’s, 80’0 90’s 2000’s music.